Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.03% |
| 2 | Technology | 14.98% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Consumer Staples | 10.71% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Driven Brands
DRVN
$2.13B
| $1.88M | ﹤0.01% |
71,500
+44,500
| +165% | +$1.29M |
|
2277
TG Therapeutics
TGTX
$7.46B
| $1.88M | ﹤0.01% |
197,600
-51,600
| -21% | -$597K |
|
2278
AudioCodes
AUDC
$250M
| $1.88M | ﹤0.01% |
+73,504
| New | +$2.11M |
|
2279
AMREP Corp
AXR
$119M
| $1.87M | ﹤0.01% |
138,574
-11,439
| -8% | -$147K |
|
2280
abrdn Physical Precious Metals Basket Shares ETF
GLTR
$2.69B
| $1.87M | ﹤0.01% |
19,500
+14,900
| +324% | +$1.41M |
|
2281
Universal Insurance Holdings
UVE
$1.2B
| $1.87M | ﹤0.01% |
+138,900
| New | +$2.08M |
|
2282
RenaissanceRe
RNR
$13.4B
| $1.87M | ﹤0.01% |
+11,800
| New | +$1.83M |
|
2283
Target Hospitality
TH
$1.74B
| $1.87M | ﹤0.01% |
311,500
+45,452
| +17% | +$177K |
|
|
DOC
2284
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $1.86M | ﹤0.01% |
106,100
+79,500
| +299% | +$1.4M |
|
2285
Hubbell
HUBB
$27B
| $1.86M | ﹤0.01% |
+10,100
| New | +$1.9M |
|
2286
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.99B
| $1.85M | ﹤0.01% |
49,400
+26,100
| +112% | +$952K |
|
|
CVET
2287
DELISTED
Covetrus, Inc. Common Stock
CVET
| $1.85M | ﹤0.01% |
110,202
+43,600
| +65% | +$762K |
|
|
CLPR
2288
Clipper Realty
CLPR
$54M
| $1.85M | ﹤0.01% |
203,857
-15,000
| -7% | -$140K |
|
|
VLTA
2289
DELISTED
Volta Inc.
VLTA
| $1.85M | ﹤0.01% |
+605,700
| New | +$2.91M |
|
|
SCTL
2290
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $1.84M | ﹤0.01% |
1,020,000
-138,200
| -12% | -$239K |
|
|
CSW
2291
CSW Industrials
CSW
$5.62B
| $1.83M | ﹤0.01% |
15,600
+2,200
| +16% | +$259K |
|
2292
Cartesian Therapeutics
RNAC
$267M
| $1.83M | ﹤0.01% |
49,680
+33,807
| +213% | +$2.11M |
|
2293
Avita Medical
RCEL
$243M
| $1.83M | ﹤0.01% |
+215,280
| New | +$1.98M |
|
2294
Movado Group
MOV
$803M
| $1.82M | ﹤0.01% |
46,600
+23,600
| +103% | +$895K |
|
2295
Invesco Taxable Municipal Bond ETF
BAB
$1.01B
| $1.82M | ﹤0.01% |
61,300
+36,975
| +152% | +$1.15M |
|
2296
Cumberland Pharmaceuticals
CPIX
$117M
| $1.82M | ﹤0.01% |
644,763
+38,100
| +6% | +$127K |
|
2297
Pampa Energía
PAM
$4.23B
| $1.82M | ﹤0.01% |
76,860
+45,300
| +144% | +$940K |
|
|
LCI
2298
DELISTED
Lannett Company, Inc.
LCI
| $1.81M | ﹤0.01% |
575,776
+61,892
| +12% | +$272K |
|
|
STZ.B
2299
DELISTED
CONSTELLATION BRANDS, INC. CLASS B
STZ.B
| $1.81M | ﹤0.01% |
7,800
-200
| -3% | -$47K |
|
|
STXB
2300
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $1.81M | ﹤0.01% |
69,000
+39,300
| +132% | +$1.12M |
|
Similar funds
Jim Simons's Q1 2022 Portfolio in Review
As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 821 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
- Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Jim Simons opened 821 new positions and closed 650 in Q1 2022.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.